PR Newswire BOCA RATON, Fla., Oct. 1, 2024 Empowering Patients with Advanced Technology and Collaborative Healthcare Solutions BOCA RATON, Fla., Oct. 1, 2024 /PRNewswire/ -- StrideMD, a leading innovator in remote patient monitoring for ...
PR Newswire NEW YORK, Oct. 1, 2024 Diabetes nonprofit proudly announces its team of runners who are shattering stigmas and proving that anyone living with diabetes can achieve extraordinary distances, no matter their diagnosis NEW YORK, ...
PR Newswire LOS ANGELES, Sept. 24, 2024 LOS ANGELES, Sept. 24, 2024 /PRNewswire/ -- Gluco-Pro Protein, a pioneering dietary supplement company founded by Nick Theurer and Dr. Matthew Cassels, is proud to announce that it has been awarded a ...
PR Newswire KANSAS CITY, Mo., Sept. 23, 2024 KANSAS CITY, Mo., Sept. 23, 2024 /PRNewswire/ -- Sun Life U.S. has teamed up for the seventh year with The Kansas City Royals Foundation for "#StrikeoutDiabetes," which supports local community ...
PR Newswire AUSTIN, Texas, Sept. 23, 2024 Company's CEO and CFO Highlights its Cutting-Edge Gene Therapy Programs AUSTIN, Texas, Sept. 23, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage ...
PR Newswire ARLINGTON, Va., Sept. 12, 2024 The #NourishMyHealth public education campaign to be featured at the ADA's Tour de Cure® and Step Out Walk to Stop Diabetes® events ARLINGTON, Va., Sept. 12, 2024 /PRNewswire/ -- Today, the ...
HONG KONG Sept 11 2024 - (ACN Newswire) - HighTide Therapeutics Inc. (2511.HK) a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases presents ...
PR Newswire SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
PR Newswire INDIANAPOLIS, Sept. 10, 2024 Detailed results were published in The Lancet and simultaneously presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024 INDIANAPOLIS, Sept. 10, 2024 ...
PR Newswire INDIANAPOLIS, Sept. 10, 2024 In QWINT-2, efsitora helped adults naďve to insulin therapy currently using and not using GLP-1 receptor agonists achieve an A1C below 7% Detailed results were published in The New England ...
Presence of high blood sugar in diabetic patients boosts cavity causing bacteria in saliva and significantly increases the risk of dental cavities.
A distinct type of immune cells was found in pancreas of type 1 diabetic people; the discovery offers target for early detection and prevention of diabetes.
WHO releases its first global guidelines for diabetes in pregnancy, aiming to prevent life-threatening complications and improve outcomes for millions of mothers and babies.
Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and lifestyle changes are key.
Researchers found patients on GLP-1 drugs were less than half as likely to die within five years, hinting at a powerful new link between metabolic health and cancer survival.
MEDINDIA
English
हिन्दी
Español
français
中文